ABERNETHY MATT

CIK 00017240972 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001724097

Recent Transactions

50 trades

Award
FATE THERAPEUTICS INC$FATE
Stock Option (Right to Buy)
2025-05-29+110,000→ 110,000 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-13$116.85/sh−1,352→ 34,775 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-02-13−2,241→ 6,725 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-13+2,241→ 37,016 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-02-13−2,566→ 5,132 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-13+2,566→ 36,127 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-13$116.87/sh−1,206→ 35,810 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-02-12+8,534→ 8,534 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Stock Option
2025-02-12+45,538→ 45,538 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-10$118.27/sh−980→ 33,561 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-02-08−1,860→ 0 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-08+1,860→ 34,541 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-01-31−2,436→ 2,437 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-01-31$152.87/sh−1,283→ 32,681 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-01-31+2,436→ 33,964 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2024-08-13−14,100→ 0 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-08-13$150.38/sh−14,100→ 31,528 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-08-13$73.60/sh+14,100→ 45,628 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-07-16$150.04/sh−900→ 31,528 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-07-16$73.60/sh+900→ 32,428 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2024-07-16−900→ 14,100 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2024-05-15$73.60/sh−15,000→ 15,000 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-05-15$140.24/sh−15,000→ 31,528 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-05-15$73.60/sh+15,000→ 46,528 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-05-14$135.66/sh−15,000→ 31,528 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2024-05-14$73.60/sh−15,000→ 30,000 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-05-14$73.60/sh+15,000→ 46,528 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2024-02-13+8,966→ 8,966 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Stock Option
2024-02-13+45,058→ 45,058 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-02-13$132.85/sh−1,352→ 31,528 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-02-08$134.21/sh−980→ 30,314 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-02-06$142.19/sh−1,280→ 29,434 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-01-31$140.72/sh−1,283→ 28,284 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2023-08-21$107.39/sh−2,132→ 27,131 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2023-02-13+10,264→ 10,264 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Stock Option
2023-02-13+63,789→ 63,789 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2023-02-08$104.19/sh−980→ 25,213 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2023-02-07$102.33/sh−2,030→ 24,333 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2023-02-07$102.42/sh−12,807→ 35,824 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2023-02-07$102.40/sh−11,491→ 24,333 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2023-02-06$105.67/sh−1,280→ 22,507 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2023-01-31$109.98/sh−1,283→ 21,357 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2022-02-08$79.65/sh−980→ 20,204 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2022-02-07$80.80/sh−2,030→ 18,175 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2022-02-07$80.78/sh−1,280→ 19,325 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2022-01-31+9,745→ 9,745 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Stock Option
2022-01-31+66,362→ 66,362 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2021-12-01$82.59/sh−1,645→ 16,349 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Stock Option
2021-02-08+49,049→ 49,049 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2021-02-08$116.85/sh−880→ 13,043 total

Companies

Recent Filings

Address

12780 EL CAMINO REAL

SAN DIEGO, CA, 92130

View on SEC.gov